Verified Nov 2026
Batteries & E-Mobility
·
South San Francisco, California
·
Since 2019
Cellares is a biotechnology company headquartered in South San Francisco, California, founded in 2019. It describes itself as an Integrated Development and Manufacturing Organization that produces living cell therapies using automated platforms, including its Cell Shuttle system. The company has roughly 200-500 employees with an estimated revenue band of $50-100 million, and serves pharmaceutical, biotechnology, and academic clients. In June 2026 it grew its Series D financing to $327 million, including a $50 million investment from Prime Radiant Partners.
Cellares at a glance
Revenue
$50-100M
Est. band
Employees
200-500
Founded
2019
Headquarters
South San Francisco, California
Industries
Automotive
Electric Vehicles
Electronics
Medical
Industrial Equipment
Overview
Cellares is a biotechnology company headquartered in South San Francisco, California, founded in 2019. It describes itself as an Integrated Development and Manufacturing Organization that produces living cell therapies using automated platforms, including its Cell Shuttle system. The company has roughly 200-500 employees with an estimated revenue band of $50-100 million, and serves pharmaceutical, biotechnology, and academic clients. In June 2026 it grew its Series D financing to $327 million, including a $50 million investment from Prime Radiant Partners.
At a glance
Attribute | Detail |
|---|---|
Founded | 2019 |
Headquarters | South San Francisco, California |
Employees | 200-500 |
Revenue | $50-100M (estimated) |
Primary capability | Batteries & E-Mobility |
What Cellares makes
The company's Cell Shuttle platform automates the production of suspension-based cell therapies, and its Cell Q system provides quality control for compliance and reproducibility.
Products and capabilities described on the company's own site include LED (source: cellares.com).
Latest developments
2026-09-23 — Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle® Platform - Cellares (cellares.com)
2026-09-16 — Cellares and GenomeFrontier Therapeutics Partner to Evaluate Automated Manufacturing for GF-CART01 on the Cell Shuttle® Platform - Cellares (cellares.com)
2026-06-15 — Cellares Grows Series D to $327 Million with $50 Million Prime Radiant Partners Investment - Cellares (cellares.com)
2026-06-09 — Cathie Wood's ARK Invest Joins Cellares' $277 Million Series D - Cellares (cellares.com)
2026-04-28 — Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel - Cellares (cellares.com)
2026-01-28 — Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation - Cellares (cellares.com)
Facilities
Cellares is headquartered in South San Francisco, California. Public sources also reference these locations:
New Jersey — pharmamanufacturing.com
Belgium — pharmamanufacturing.com
Company details
Cellares is privately held and has a commercial supply agreement with Cabaletta Bio, signed in April 2026, to scale production of rese-cel. Cellares was founded in 2019, has an estimated 200-500 employees, and is headquartered in South San Francisco, California.
Frequently asked questions
What does Cellares make?
Cellares is a biotechnology company headquartered in South San Francisco, California, founded in 2019. It describes itself as an Integrated Development and Manufacturing Organization that produces living cell therapies using automated platforms, including its Cell Shuttle system. The company has roughly 200-500 employees with an estimated revenue band of $50-100 million, and serves pharmaceutical, biotechnology, and academic clients. In June 2026 it grew its Series D financing to $327 million, including a $50 million investment from Prime Radiant Partners.
Where is Cellares headquartered?
Cellares is headquartered in South San Francisco, California (345 Allerton Ave, South San Francisco, California, 94080).
When was Cellares founded?
Cellares was founded in 2019.
How big is Cellares?
Cellares has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.